Vis enkel innførsel

dc.contributor.authorDavidson, Rebecca K.
dc.contributor.authorFæste, Christiane Kruse
dc.contributor.authorUhlig, Silvio
dc.contributor.authorTukun, Feng-Ling
dc.contributor.authorLian, Hans Edvin
dc.contributor.authorSolvang, Hans Arne
dc.contributor.authorThorvaldsen, Renate
dc.contributor.authorFolkow, Lars
dc.contributor.authorSanchez Romano, Javier
dc.contributor.authorKilvær, Marianne V.
dc.contributor.authorHolmgren, Karin Elisabeth
dc.contributor.authorNymo, Ingebjørg Helena
dc.date.accessioned2023-01-09T12:53:48Z
dc.date.available2023-01-09T12:53:48Z
dc.date.issued2022-12-17
dc.description.abstractReindeer (Rangifer tarandus tarandus) are exposed to the pathogenic parasitic nematode Elaphostrongylus rangiferi during grazing. The severity of disease is dose-dependent. Prophylactic anthelmintic treatment is needed to improve animal health and reindeer herding sustainability. Herds are traditionally only gathered once during the summer, requiring a drug with a persistent effect. In this study we investigated the suitability of long-acting eprinomectin, given as a single subcutaneous injection at 1mg/kg bodyweight in adult reindeer and calves. Plasma and faeces concentrations were determined using ultra-high performance liquid chromatography high resolution mass spectrometry (UHPLC-HRMS). Plasma concentrations remained above the presumed effect level of 2ng/mL for 80 days, demonstrating the drug's potential. Pharmacokinetic parameters were compared to other species using allometric scaling. Calves and adults had slightly different profiles. No viable faecal nematode eggs were detected during treatment. Eprinomectin was measurable in the reindeer faeces up to 100 days, which is of environmental concern.en_US
dc.identifier.citationDavidson RK, Fæste CK, Uhlig S, Tukun F, Lian H, Solvang HA, Thorvaldsen R, Folkow P., Sanchez Romano J, Kilvær MV, Holmgren KE, Nymo IH. Pharmacokinetics of a long-acting subcutaneous eprinomectin injection in semi-domesticated reindeer (Rangifer tarandus tarandus) - a pilot study. Environmental Toxicology and Pharmacology. 2022;97en_US
dc.identifier.cristinIDFRIDAID 2096454
dc.identifier.doi10.1016/j.etap.2022.104041
dc.identifier.issn1382-6689
dc.identifier.issn1872-7077
dc.identifier.urihttps://hdl.handle.net/10037/28091
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.journalEnvironmental Toxicology and Pharmacology
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S1382668922002344?via%3Dihub
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.rightsAttribution 4.0 International (CC BY 4.0)en_US
dc.titlePharmacokinetics of a long-acting subcutaneous eprinomectin injection in semi-domesticated reindeer (Rangifer tarandus tarandus) - a pilot studyen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution 4.0 International (CC BY 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution 4.0 International (CC BY 4.0)